tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
US Market
RNAC
Cartesian Therapeutics
RESEARCH TOOLSreports

Cartesian Therapeutics (RNAC) Stock News & Sentiment

Compare
1,149 Followers
RNAC’s Descartes-08 Moves Toward Phase 2 in Rare Muscle Disease: What Investors Should Watch
Premium
Company Announcements
RNAC’s Descartes-08 Moves Toward Phase 2 in Rare Muscle Disease: What Investors Should Watch
11d ago
RNAC
Cartesian Therapeutics: Reaffirmed AURORA Timelines and Solid Cash Runway Underpin Needham Buy Rating and $42 Target
Premium
Ratings
Cartesian Therapeutics: Reaffirmed AURORA Timelines and Solid Cash Runway Underpin Needham Buy Rating and $42 Target
14d ago
RNAC
RNAC Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RNAC Upcoming Earnings Report: What to Expect?
21d ago
RNAC
Cartesian Therapeutics Outlines 2026 Outlook and Trial Progress
Premium
Company Announcements
Cartesian Therapeutics Outlines 2026 Outlook and Trial Progress
2M ago
8K
RNAC
Strategic Positioning and Unique Treatment Profile Drive Buy Rating for Cartesian Therapeutics
Premium
Ratings
Strategic Positioning and Unique Treatment Profile Drive Buy Rating for Cartesian Therapeutics
3M ago
RNAC
Strategic Pivot and Promising Clinical Data Justify Buy Rating for Cartesian Therapeutics
Premium
Ratings
Strategic Pivot and Promising Clinical Data Justify Buy Rating for Cartesian Therapeutics
4M ago
RNAC
Strategic Realignment Boosts Cartesian Therapeutics’ Prospects: Gil Blum Issues Buy Rating
Premium
Ratings
Strategic Realignment Boosts Cartesian Therapeutics’ Prospects: Gil Blum Issues Buy Rating
4M ago
RNAC
More RNAC News >

RNAC News on the Web

Squarepoint Ops LLC Acquires Significant Stake in Cartesian Therapeutics Inc
GuruFocus News
Bullish
RNAC’s Descartes-08 Moves Toward Phase 2 in Rare Muscle Disease: What Investors Should Watch
TipRanks News
Bullish
Wedbush Reaffirms Their Buy Rating on Cartesian Therapeutics (RNAC)
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Cartesian Therapeutics (RNAC) and Vertex Pharmaceuticals (VRTX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Design Therapeutics (DSGN) and Cartesian Therapeutics (RNAC)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Cartesian Therapeutics (RNAC)
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
RNAC
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RNAC’s Media Buzz Sentiment?
1 articles about RNAC were published this week. In an average week, 3.25 articles are published.
    What is RNAC’s weekly average amount of articles?
    In an average week, 3.25 articles about RNAC are published.
      What is RNAC’s News Sentiment?
      100% of articles about RNAC were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        HYPRHyperfine
        KMTSKestra Medical Technologies Ltd.
        OVIDOvid Therapeutics
        PYPDPolyPid
        Showing the stocks with the most bullish news sentiment over the past week